← Leaderboards
Hyeonjoo Cheon
Cleveland Clinic Lerner Com-Cwru
$572,472
Attributed
$572,472
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225.8K · FY2017–22$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$572,472 · 2
By mechanism
R21$413,972 · 1
R03$158,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Ruth A Keri$12,224,731
- Paul L Fox$31,501,589
- Ryan Christopher Gimple$189,104
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsCancer TherapyNeoplastic CellTherapeutic AgentsResistanceMalignant NeoplasmsKnock-DownMediatingPhosphorylationSignal TransductionResponseBinding SitesNon-Small-Cell Lung CarcinomaChemotherapyCancer CellInterferonsAnti-Pd-L1Blocking AntibodiesCombined Modality TherapyAntineoplastic AgentsAffectCytotoxicityCell LineCell Killing
Grant awards (5)
PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells$134,173
R21 · FY2022 · CA · contact PI
PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells$53,996
R21 · FY2022 · CA · contact PI
PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells$225,803
R21 · FY2021 · CA · contact PI
p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage$79,250
R03 · FY2018 · CA · contact PI
p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage$79,250
R03 · FY2017 · CA · contact PI